<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> are at risk for developing metachronous <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The purpose of posttreatment surveillance is to detect and remove <z:e sem="disease" ids="C0850639" disease_type="Neoplastic Process" abbrv="">premalignant lesions</z:e> to prevent metachronous <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>OBJECTIVE: The aim of this study was to investigate the incidence of and predictive factors for metachronous <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> in patients with newly diagnosed <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>DESIGN AND PATIENTS: The data on <z:hpo ids='HP_0000001'>all</z:hpo> patients with newly diagnosed <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> between 1995 and 2006 were obtained from the Rotterdam <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> Registry in The Netherlands and studied for metachronous <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>MAIN OUTCOME MEASURES: The annual incidence rate and the standardized incidence ratios were calculated </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: In total, <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> was diagnosed in 10,283 patients; there were 39,974 person-years of follow-up </plain></SENT>
<SENT sid="6" pm="."><plain>The mean annual incidence rate of metachronous <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> was 314/100,000 person-years at risk during 10 years of follow-up, corresponding with a mean annual incidence of 0.3% and a cumulative incidence of 1.1% at 3 years, 2.0% at 6 years, and 3.1% at 10 years </plain></SENT>
<SENT sid="7" pm="."><plain>The incidence of metachronous <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> after resection of a first <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> is significantly higher than the incidence of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> in an age- and sex-matched general population (standardized incidence ratio 1.3, 95% CI 1.1-1.5) </plain></SENT>
<SENT sid="8" pm="."><plain>This difference is especially seen during the first 3 years after first <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> diagnosis (standardized incidence ratio 1.4, 95% CI 1.1-1.8) </plain></SENT>
<SENT sid="9" pm="."><plain>The presence of synchronous <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> was the only significant risk factor for developing metachronous <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (relative risk 13.9, 95% CI 4.7-41.0) </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: Despite the availability of colonoscopy, metachronous <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> is still seen during follow-up in patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>; the highest risk is during the first 3 years after initial diagnosis </plain></SENT>
<SENT sid="11" pm="."><plain>For this reason, a follow-up colonoscopy is useful at a short-term interval after <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> diagnosis </plain></SENT>
<SENT sid="12" pm="."><plain>The presence of synchronous <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> at the time of first <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> diagnosis is the only predictive risk factor for developing metachronous <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="13" pm="."><plain>Tailored surveillance programs may be considered in patients with a diagnosis of synchronous <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
</text></document>